Clinical trial · Interventional
Pilot Study of Transcranial Stimulation (tDCS)to Relieve Neuropathic Pain in Cancer Patients
Pilot Study on Safety and Efficacy of the Non-invasive Transcranial Stimulation (tDCS) to Relieve Neuropathic Pain in Cancer Patients
NCT01948050CI-TRIAL-00015068completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a pilot study designed to collect preliminary data on safety and efficacy of transcranial direct current stimulation (tDCS) to relieve pain in cancer patients who developed neuropathic pain in the affected area after a surgical intervention, radiation therapy, or chemotherapy to treat the disease.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| non-invasive transcranial direct current stimulation (tDCS) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- real tDCS stimulation
- description
- non-invasive transcranial direct current stimulation (tDCS) at 2 milliamiampers (2mA)for 20 minutes at each session, on five consecutive days.
- interventionNames
- Device: non-invasive transcranial direct current stimulation (tDCS)
- type
- SHAM_COMPARATOR
- label
- Sham tDCS
- description
- sham non-invasive transcranial direct current stimulation (tDCS) consisting of 30 seconds of tDCS stimulation at 2mp and 19 minutes and 30 seconds of tdcs at 0mp stimulation,on five consecutive days.
- interventionNames
- Device: non-invasive transcranial direct current stimulation (tDCS)
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Adult male and female patients with cancer who developed neuropathic pain in the affected area secondary the surgical procedure, chemotherapy or radiation that meet the following Inclusion/Exclusion criteria: Inclusion Criteria: Pain on the side of the lesion * Spontaneous pain with a score for "worst pain in the last 24 hours" \>4 on a numeric scale 0-10 * Must present the following symptoms and signs: * Continuous burning, shooting, or lancinating pain. * Presence of hyperesthesia * Presence of hyperalgesia (to pinprick) and/or allodynia (to light touch) Exclusion Criteria: * Uncontrolled hypertension, uncontrolled diabetes, uncontrolled cardiovascular disease * Pain/painful conditions unrelated to the cancer or related treatment * Pregnancy * History of seizures/epilepsy * Any implanted devices (e.g. a cardio stimulator, etc) * Active illegal drug/alcohol abuse * Unable to follow directions or complete tools in English
References
Publications (0)
Data not yet available
No reference posted for this study.